Be Clinical Raises $2.2 Million in Seed Extension
Be Clinical, a New Delhi-based science-driven skincare brand, has successfully raised $2.2 million in a seed extension round. The funding was led by Sauce, with participation from V3 Ventures, Sangeet Agrawal, Navin Parwal, Arjun Purkayastha, and Shaunak Chirayu Amin.
About Be Clinical
Be Clinical specializes in providing effective, gender-neutral skincare products that are both sustainable and tailored to individual skin needs. The brand emphasizes a science-driven approach to skincare, ensuring compatibility with a diverse range of skin types.
Leadership and Vision
Founded by Hemangi Dhir, Be Clinical is committed to expanding its reach and enhancing its product offerings. Dhir has been instrumental in guiding the company’s mission to offer sustainable skincare solutions that cater to a broad audience.
Strategic Use of Funds
The newly acquired funds from this seed extension round are expected to support Be Clinical in expanding its product line and strengthening its market presence. Specific plans for the allocation of these funds were not disclosed, but such investments typically aim to enhance product development and marketing efforts.
Investor Confidence
The involvement of prominent investors such as Sauce and V3 Ventures highlights the confidence in Be Clinical’s potential to grow within the competitive skincare industry. The backing from individual investors like Sangeet Agrawal and Navin Parwal further underscores the belief in the brand's vision and market strategy.
As Be Clinical continues to develop its unique skincare solutions, the company is poised to make significant strides in both local and international markets.